Insitu Biologics

About:

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and proprietary treatments.

Website: http://insitubiologics.com/

Twitter/X: InSituBiologics

Top Investors: Manhattan Street Fund

Description:

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and proprietary treatments using its Matrix BioHydrogel. The company's platform develops and manufactures implantable time release products composed of its proprietary tunable and bio-polymeric hydro-gel by using hard particulates in soft matrix, enabling patients to get relieve from peri-operative regional pain by a long-lasting and long-acting non-opiate painkiller.

Total Funding Amount:

$6.97M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Minnesota City, Minnesota, United States

Founded Date:

2014-01-01

Contact Email:

katie(AT)insitubiologics.com

Founders:

Bill Taylor, James Segermark

Number of Employees:

11-50

Last Funding Date:

2021-02-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai